Vanguard Group Inc Cytek Biosciences, Inc. Transaction History

Vanguard Group Inc

  • $5.12 Trillion
  • Q2 2024

A detailed history of Vanguard Group Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,746,178 shares of CTKB stock, worth $61.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,746,178
Previous 12,012,805 2.22%
Holding current value
$61.1 Million
Previous $80.6 Million 18.69%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$5.3 - $6.91 $1.41 Million - $1.84 Million
-266,627 Reduced 2.22%
11,746,178 $65.5 Million
Q1 2024

May 10, 2024
BUY
$6.29 - $9.15 $768,040 - $1.12 Million
122,105 Added 1.03%
12,012,805 $80.6 Million
Q4 2023

Feb 14, 2024
BUY
$4.1 - $9.51 $3.33 Million - $7.72 Million
811,279 Added 7.32%
11,890,700 $108 Million
Q3 2023

Nov 14, 2023
BUY
$5.52 - $9.5 $2.55 Million - $4.38 Million
461,142 Added 4.34%
11,079,421 $61.2 Million
Q2 2023

Aug 14, 2023
BUY
$6.69 - $11.99 $18.3 Million - $32.8 Million
2,732,791 Added 34.66%
10,618,279 $90.7 Million
Q1 2023

May 15, 2023
BUY
$8.44 - $13.47 $965,713 - $1.54 Million
114,421 Added 1.47%
7,885,488 $72.5 Million
Q4 2022

Feb 10, 2023
BUY
$9.71 - $15.86 $811,387 - $1.33 Million
83,562 Added 1.09%
7,771,067 $79.3 Million
Q3 2022

Nov 14, 2022
BUY
$10.96 - $15.45 $15.5 Million - $21.8 Million
1,413,703 Added 22.53%
7,687,505 $113 Million
Q2 2022

Aug 12, 2022
SELL
$7.41 - $11.56 $580,114 - $905,009
-78,288 Reduced 1.23%
6,273,802 $67.3 Million
Q1 2022

May 13, 2022
BUY
$9.89 - $17.25 $50.8 Million - $88.7 Million
5,140,344 Added 424.21%
6,352,090 $68.5 Million
Q4 2021

Feb 14, 2022
BUY
$16.14 - $25.04 $248,136 - $384,964
15,374 Added 1.29%
1,211,746 $19.8 Million
Q3 2021

Nov 12, 2021
BUY
$17.52 - $27.93 $21 Million - $33.4 Million
1,196,372 New
1,196,372 $25.6 Million

Others Institutions Holding CTKB

# of Institutions
135
Shares Held
73.9M
Call Options Held
200
Put Options Held
100
View Full List

About Cytek Biosciences, Inc.

CTKB Quotes by TradingView
  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $700M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email